Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2007
06/26/2007US7235529 Brain-associated inhibitor of tissue-type plasminogen activator
06/26/2007US7235528 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient
06/26/2007US7235527 Polypeptide for use in the treatment bone disorders and osteoarthritis
06/26/2007US7235525 administering an effective amount of erythropoietin for treatment to a patient with renal failure-associated osteodystrophy or renal failure-associated osteoporosis
06/26/2007US7235523 Methods for the treatment of hepatic disorders
06/26/2007US7235403 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence
06/26/2007US7235401 Expression vector which comprises live reporter molecule sequence unregulatory control of cell cycle phase-specific expression elements for use in continous monitoring of cell cycle progression
06/26/2007US7235385 Methods for enhancing expression of recombinant proteins
06/26/2007US7235381 Expressed sequence tags and encoded human proteins
06/26/2007US7235375 Organic anion transport proteins
06/26/2007US7235374 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
06/26/2007US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample
06/26/2007US7235371 Human osteoclast derived cathepsin
06/26/2007US7235367 Crystallized membrane protein; for use as an anticarcinogenic agent
06/26/2007US7235366 Methods of identifying agonists and antagonists of opioid receptors
06/26/2007US7235363 Detecting modulators of brain membrane protein; obtained membrane protein incubated with ligand and labeled compound, measure level of binding
06/26/2007US7235362 Compositions and methods for protein isolation
06/26/2007US7235360 Generating transgenic eukaryotic cells which secrete immunoglobulins using vector transformation and site specific recombination; bioreactors and heterologous gene expression
06/26/2007US7235269 comprises mixing acetone with acid extracted solubles from a defatted soybean material to form a precipitate, and diluting and ultrafiltering to obtain a retentate
06/26/2007US7235245 Chimeric lyssavirus nucleic acids and polypeptides
06/26/2007US7235244 Compositions and methods for treating papillomavirus-infected cells
06/26/2007US7235243 Immunological combination compositions and methods
06/26/2007US7235242 use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide
06/26/2007US7235241 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
06/26/2007US7235240 A mutein of IL-15 at least one deletion or substitution in two positions of the amino acid sequence; transplant rejection, autoimmune diseases, inflammatory bowel disease, skin disorders, gatrointestinal disorders, vision defects; antiarthritic, anticarcinogenic, and antidiabetic agents
06/26/2007US7235239 Antibodies to a chemokine expressed in inflamed adenoid
06/26/2007US7235238 Antibodies that bind receptor protein designated 2F1
06/26/2007US7235235 Alphavirus RNA replicon systems
06/26/2007US7235233 Fiber protein of seretype 11, 16, 35, 40 and/or 51; efficient transduction; nucleic acid transfer
06/26/2007US7235232 Interferon alpha hybrids
06/26/2007CA2321269C Corn silk gene and regulatory region
06/26/2007CA2301716C Diagnosis kit for skin test and method for carrying out the same
06/26/2007CA2295316C Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
06/26/2007CA2290739C New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
06/26/2007CA2265464C Therapy for .alpha.-galactosidase a deficiency
06/26/2007CA2216827C Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
06/26/2007CA2216704C Novel peptides and remedy for bone diseases containing the same as active ingredient
06/26/2007CA2186423C Protein which induces interferon-gamma production by immunocompetent cell
06/26/2007CA2176215C Stable cell lines capable of expressing the adeno-associated virus replication gene
06/26/2007CA2157118C Isolation of components of interest from milk
06/26/2007CA2154445C Lysosomal targeting of immunogens
06/26/2007CA2139862C Use of p97 and iron binding proteins as diagnostic and therapeutic agents
06/26/2007CA2065797C Monoclonal antibody, polypeptide and production thereof
06/21/2007WO2007070542A2 Nanoprobes for detection or modification of molecules
06/21/2007WO2007070509A2 Epithelial sodium channel inhibiting agents and uses therefor
06/21/2007WO2007070488A2 Integrin alpha l i domain mutants with increased binding affinity
06/21/2007WO2007070315A2 Improved production of glycoproteins using manganese
06/21/2007WO2007069817A1 Peptides for inhibiting transglutaminase
06/21/2007WO2007069782A1 L-amino acid producing bacterium and method of producing l-amino acid
06/21/2007WO2007069666A1 Nuclear reprogramming factor
06/21/2007WO2007069423A1 Diagnostic marker for allergy
06/21/2007WO2007069368A1 Peptides originating in hepatitis c virus
06/21/2007WO2007069249A2 Toxin-like polypeptides, polynucleotides encoding same and uses thereof
06/21/2007WO2007069247A2 Polynucleotides and polypeptide of human kv1.3, compositions comprising same and methods of using same
06/21/2007WO2007068913A2 SRCR-B Domain Containing Proteins
06/21/2007WO2007068902A2 Vaccine
06/21/2007WO2007068803A1 Novel neurotrophic factor protein and uses thereof
06/21/2007WO2007068784A1 Novel neurotrophic factor protein and uses thereof
06/21/2007WO2007068736A2 New chemokine antagonists
06/21/2007WO2007068735A1 Polypeptides having antimicrobial activity and polynucleotides encoding same
06/21/2007WO2007068718A1 Polypeptide protracting tags
06/21/2007WO2007068310A1 Device for the early and rapid immunochromatographic detection of hiv and uses thereof
06/21/2007WO2007068240A2 Peptides interacting with alpha-helical coiled-coil structures and/or coiled-coil sequences, substances derived therefrom, and use thereof
06/21/2007WO2007068163A1 Hiv fusion inhibitor peptides and use thereof
06/21/2007WO2007068115A1 Method of detecting and reducing boar taint using nuclear receptors
06/21/2007WO2007068105A1 Method of diagnosing amyotrophic lateral sclerosis
06/21/2007WO2007068053A1 Recombinant protein production
06/21/2007WO2007068047A1 Multimeric fc receptor polypeptides
06/21/2007WO2007068039A1 Treatment of weight gain in estrogen deficient mammals
06/21/2007WO2007052238A8 Chimeric antigens and vaccines
06/21/2007WO2007044671A3 Thermostable viral polymerases and methods of use
06/21/2007WO2007041439A3 Centrosomal proteins, nucleic acids and method of use thereof
06/21/2007WO2007039761A3 Crystal structure of cd44 and its use
06/21/2007WO2007038316A3 Human cytomegalovirus latency promoting genes, related virus variants and methods of use
06/21/2007WO2007035650A3 Methods for genetic control of insect infestations in plants and compositions thereof
06/21/2007WO2007034507A3 Tetravalent dengue specific domain iii based chimeric recombinant protein
06/21/2007WO2007032523A3 Esterase gene and use thereof
06/21/2007WO2007032522A3 Branched-chain amino acid aminotransferase gene and use thereof
06/21/2007WO2007030637A3 Hiv gp120 crystal structure and its use to identify immunogens
06/21/2007WO2007020520A3 Antigenic peptides and their use
06/21/2007WO2007019575A3 Methods for treating b-cell malignancies using taci-ig fusion molecule
06/21/2007WO2007007327A3 Il-32 modulators
06/21/2007WO2007002469A3 Therapeutic compositions and methods using transforming growth factor-beta mimics
06/21/2007WO2006133931A3 Identification of jak/stat pathway modulating genes by genome wide rnai screening
06/21/2007WO2006129204A3 Rnai for control of insects and arachnids
06/21/2007WO2006119035A3 Vegf variants
06/21/2007WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins
06/21/2007WO2006087340A8 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor
06/21/2007WO2006085965A3 Methods of protecting plants from pathogenic fungi
06/21/2007WO2006081350A8 Methods and compositions for the diagnosis and treatment of schizophrenia
06/21/2007WO2006078657A3 Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
06/21/2007WO2005049797A3 Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof
06/21/2007WO2005005615A3 Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer
06/21/2007WO2004078135A3 LIGANDS THAT BIND TO THE AMYLOID-β PRECURSOR PEPTIDE AND RELATED MOLECULES AND USES THEREOF
06/21/2007WO2003089616A3 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
06/21/2007WO2003064628A3 Novel proteins and nucleic acids encoding same
06/21/2007US20070143876 Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof
06/21/2007US20070143873 Potassium channels
06/21/2007US20070143872 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
06/21/2007US20070143871 Non-human transgenic animal models for hepatocellular carcinoma